Posted by Michael Wonder on 02 Jan 2020
Biosimilar trastuzumab and rituximab on the PBS - information for health professionals and patients
2 January 2019 - New biosimilar brands of trastuzumab (Ontruzant) and rituximab (Truxima) have listed on the PBS on 1 January 2020.
Information about these listings for health professionals and patients can be found on the Biosimilar Awareness Initiative web page.
Further information about biosimilar uptake drivers applied to rituximab is also available on the ‘Biosimilars on the PBS’ webpage of this website.
The PI for Truxima is not listed on the TGA website. Strangely, the TGA has published an AusPAR for Truxima.
This is not good enough. Medicines should not be listed on PBS until their PI is listed on the TGA website.
